SCHEMBL25849170

SCHEMBL25849170

O=C(CCC(=O)OCc1ccccc1)NCCN1C(=O)C2C3C=CC(O3)C2C1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.49
ALDH1A1 P00352 10/20 0.47
CASP1 P29466 1/20 0.46
OPRM1 P35372 1/20 0.45
OPRD1 P41143 1/20 0.45
OPRK1 P41145 1/20 0.45
TAAR1 Q96RJ0 1/20 0.42
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CCKBR P32239 1/20 0.40
GAA P10253 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25849155 0.87 PKM (0.51) PKMALDH1A1CASP1OPRM1OPRD1
SCHEMBL25849171 0.87 ALDH1A1 (0.44) ALDH1A1TAAR1MEN1POLBMAPT
SCHEMBL17975756 0.75 ALDH1A1 (0.46) PKMALDH1A1OPRM1OPRD1OPRK1
SCHEMBL25849172 0.73 PKM (0.55) PKMALDH1A1CASP1MAPTSMN1; SMN2
SCHEMBL22100053 0.72 PKM (0.49) PKMALDH1A1OPRM1OPRD1OPRK1
SCHEMBL25849159 0.72 CYP2C19 (0.46) ALDH1A1CASP1MEN1MAPTKMT2A
SCHEMBL12409525 0.72 HTT (0.62) ALDH1A1TAAR1MEN1POLBMAPT
SCHEMBL25857043 0.72 ALDH1A1 (0.52) PKMALDH1A1CASP1OPRM1OPRD1
SCHEMBL25857121 0.72 ALDH1A1 (0.52) PKMALDH1A1OPRM1OPRD1OPRK1
SCHEMBL11448075 0.70 KMT2A (0.56) ALDH1A1TAAR1MEN1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203474-A1 COMPOUND, SOLID CARRIER INCLUDING THE SAME AND METHOD FOR PREPARING NUCLEIC ACID INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2023-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203474-A1 COMPOUND, SOLID CARRIER INCLUDING THE SAME AND METHOD FOR PREPARING NUCLEIC ACID SNRPA, NSUN2, POLRMT PKM 1412/4885ALDH1A1 2601/4885CASP1 3973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.